DDDIX
Price
$27.24
Change
+$0.49 (+1.83%)
Updated
Jul 31 closing price
Net Assets
113.12M
VIMSX
Price
$88.38
Change
-$0.07 (-0.08%)
Updated
Jul 31 closing price
Net Assets
223.97B
Interact to see
Advertisement

DDDIX vs VIMSX

DDDIX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
DDDIX vs. VIMSX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDIX is a StrongBuy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 224B vs. DDDIX (113M). VIMSX pays higher dividends than DDDIX: VIMSX (1.20) vs DDDIX (0.00). DDDIX was incepted earlier than VIMSX: DDDIX (15 years) vs VIMSX (28 years). DDDIX (1.51) is less costly to investors than VIMSX (0.17). DDDIX is a more actively managed with annual turnover of: 88.00 vs. VIMSX (16.00). DDDIX has a lower initial minimum investment than VIMSX: DDDIX (0) vs VIMSX (3000). DDDIX annual gain was more profitable for investors over the last year : 33.40 vs. VIMSX (13.46). VIMSX return over 5 years is better than : 35.82 vs. DDDIX (-7.50).
DDDIXVIMSXDDDIX / VIMSX
Total Expense Ratio1.510.17888%
Annual Report Gross Expense Ratio1.510.17888%
Fund Existence15 years28 years-
Gain YTD30.77311.625265%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets113M224B0%
Annual Yield % from dividends0.001.20-
Returns for 1 year33.4013.46248%
Returns for 3 years24.5043.3257%
Returns for 5 years-7.5035.82-21%
Returns for 10 years66.14158.9942%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLNIX28.880.32
+1.12%
Morgan Stanley Instl Glbl Concntr I
BIRKX25.160.17
+0.68%
BlackRock Sust Awr Advtg Lg Cp Cr K
AAUTX37.270.21
+0.57%
Thrivent Large Cap Value A
LBSAX40.320.01
+0.02%
Columbia Dividend Income A
BIPSX44.24-2.08
-4.49%
ProFunds Biotechnology UltraSector Svc